News

The panel, created more than 60 years ago, helps the CDC determine who should be vaccinated against a long list of diseases, ...
At the first meeting of a new group of vaccine advisers to the US Centers for Disease Control and Prevention, the committee announced new plans to study established vaccine guidelines.
New members of the ACIP panel raised questions about the evidence supporting COVID vaccines, and signaled plans to look at other established shots, like those for measles and hepatitis B.
On day one of the highly anticipated first meeting of the CDC's newly formed vaccine advisory committee, members debated the ...
The Centers for Disease Control and Prevention's vaccine advisory committee wrapped up the first day of its meeting since ...
Alternatives to weekly injections of weight-loss drugs may be on the way. A monthly dose of a new drug called MariTide helped ...
John Mascarenhas, MD, discusses the rationale, mechanism, and design of the phase 1 INCA33989-101 and -102 trials investigating a CAL-R–targeted antibody for patients with essential thrombocythemia.
Bio-Techne Corporation (NASDAQ:TECH) is one of the best S&P 500 stocks with huge upside potential. On June 24, Bio-Techne ...